ISSX Africa Workshop

Julius O. Enoru

Pharmacogenomics - Julius Enoru

Julius O Enoru is a Director (Senior Principal Research Scientist) at the Department of Qualitative Translational and ADME Sciences (QTAS), AbbVie Pharmaceutical Research & Development, South San Francisco, CA, USA. He holds a Ph.D. in Molecular Biology from Vrije Universiteit Brussels(VUB), Belgium and completed a Postdoctoral Research Fellowship program in Drug Metabolism and Pharmacokinetics, at Wyeth Pharmaceuticals (now Pfizer), Collegeville, Pennsylvania. Julius is a subject matter expert in Translational ADME sciences, currently responsible for oversight of pre-FIH In Vitro ADME Sciences functions at the AbbVie South San Francisco, CA site. He has contributed to many INDs, NDAs and responses to DDI enquiries from regulatory agencies. Julius represents AbbVie on the pharmaceutical industry consortium – International Consortium for Innovation and Quality in Pharmaceutical Development – Guidelines for development of Targeted Covalent Inhibitors Working Group. He has been a mentor to many students and early career scientists. Julius is enthusiastic about the advancements of xenobiotic research in the African continent and seeks to find partners and establish collaboration with industry/academic colleagues to continue advancing the field of ADME. Julius is a member of ISSX, AAPS, ASCPT and other professional organizations.